Global Epinephrine Market

Global Epinephrine Market Insights

The Global epinephrine market is estimated to witness a high CAGR during the forecast period. The growth of the epinephrine market is anticipated to increase with the growing pharmaceutical industry, along with other factors such as rise in number of patient prone to several allergies, enhancement in the production, and increasing prevalence of the various chronic diseases. Moreover, increase in number of patients allergic to dust, insect bites, venom, and food additives is further expected to drive the market growth. Innovations and advancements in the field of pharmaceutical are directly impacting the epinephrine market. Epinephrine, more commonly known as adrenaline (a crystalline sympathomimetic hormone C9H13NO3), is secreted by the medulla of the adrenal glands.  Epinephrine is found in small amounts in the body and is essential for maintaining cardiovascular homeostasis because of its ability to divert blood to tissues under stress. With changing lifestyle and adulterated food some people have lack of epinephrine in the body. With the help of Epinephrine, the performance and function of the body can be brought back to normal in case of an attack. However, various side effects including disorientation, impaired memory, anxiety, and psychomotor agitation among others along with strict government laws and regulations is expected to hamper the growth of market

Global Epinephrine Market: Type Insights

On the basis of type, the Global Epinephrine market can be segmented into epinephrine prefilled syringe, combination epinephrine products, and epinephrine auto-injector. Epinephrine auto-injector usually comes with a prefilled automatic injection device containing a solution (liquid) and in vials to inject it under the skin or into the muscle. Mostly, automatic injection devices contain enough solution for one dosage of epinephrine. Epinephrine prefilled syringe is used for manual infection during emergency.

Global Epinephrine Market: By Application

On the basis of application, the global epinephrine market can be classified into cardiac arrest, anaphylaxis among others. During cardiac arrest  the top priority is to maximize the amount of blood flow through the coronary artery. Epinephrine, when injected into an intravenous fluid solution, which increases the coronary artery pressure thereby promoting increased coronary blood flow. Sometimes increased doses of epinephrine quicken the response, but some studies have shown that brain and heart damage are some of the side effects. Anaphylaxis is a serious and life-threatening allergic reaction. The most common anaphylactic reactions are the result to foods, insect stings, medications and latex. If the person is allergic to a substance, then the person’s immune system overreacts to this allergen by releasing chemicals that cause allergy symptoms. Injection of epinephrine into the blood stream causes an increased blood flow throughout the body. The relief is only temporary due to the short half-life of adrenaline; therefore, immediate hospitalization is required to ensure safety to the individual.

Global Epinephrine Market: By Region

North America is expected to witness considerable growth for the epinephrine market, owing to increased technological advancement in the field of medical science and the growing number of patients in the region. The presence of a number of ongoing research and development projects in the U.S is expected to positively impact the market of epinephrine in the region. Asia-Pacific is projected to occupy a significant market share during the forecast period. Growing technological growth along with medical development in China, Taiwan, and South Korea are expected to be the prime factors contributing to the growth of epinephrine industry.

Global Epinephrine Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are Aquestive Therapeutics, Walgreens and Bausch Health Companies.

Global Epinephrine Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Global Epinephrine Market: Share & Competitor Analysis

Some of the key players operating in the Epinephrine are Pfizer, Grand Pharma, Harvest Pharmaceuticals, Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC, ALK Abello A/S, Impax, Emerade and Tianjin Jinyao Group.

Please note: This is not an exhaustive list of companies profiled in the report.

In August 2018, the FDA granted fast track designation for the epinephrine nasal spray

In April 2018, Aquestive Therapeutics began the Phase-1 clinical trials for its complex molecule programs- AQST-108 epinephrine molecule for anaphylaxis, which is administered via sublingual route